Acuitas, CureVac settle lawsuit over COVID-19 vaccine
- 26-Apr-2024
Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas’ lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia federal court. Acuitas sued CureVac last year in U.S. District Court for the Eastern District of Virginia, claiming its scientists should have been named as co-inventors of CureVac […]
CureVac slashes COVID-19 vaccine production plans
- 14-Sep-2021
German biotech firm CureVac said on Tuesday it cancelled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners, after rivals with approved shots have boosted production. Agreements with Celonic Group of Switzerland and Germany’s Wacker would be terminated but existing production deals with Rentschler Biopharma and Novartis would remain unchanged, CureVac said […]
GSK, CureVac’s next-gen COVID-19 vaccine shows promise
- 16-Aug-2021
GlaxoSmithKline and CureVac said a study on macaque monkeys showed their jointly-developed mRNA COVID-19 vaccine candidate to be “strongly improved” in protecting against the virus compared with CureVac’s first attempt. The encouraging news on its “second-generation” vaccine gave CureVac’s German-listed shares an 8% lift, as the stock gradually recovers from a slump in June when […]
CureVac fails in COVID-19 vaccine trial with 47% efficacy
- 17-Jun-2021
German biotech CureVac said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study’s main goal
GSK buys 10% of CureVac in vaccine tech deal
- 20-Jul-2020
GSK and CureVac, backed by Microsoft billionaire Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases
Germany takes 300 million euro stake in firm developing COVID-19 vaccine
- 15-Jun-2020
The move was agreed with SAP co-founder Dietmar Hopp - who is an early backer and owner of a stake of more than 80% in CureVac